findmyKOL
Clinical trialNCT02291913CompletedPhase 2Interventional

Everolimus Combined With Anti-estrogen Therapy in Hormone-Receptor-Positive HER-2 Negative Advanced Breast Cancer

SponsorSCRI Development Innovations, LLCEnrollment48Breast Cancer
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Florida Cancer Specialists-South

    Fort Myers, Florida, United States

  • Memorial Cancer Center

    Hollywood, Florida, United States

  • Woodlands Medical Specialists

    Pensacola, Florida, United States

  • Florida Cancer Specialists-East

    West Palm Beach, Florida, United States

  • Hope Cancer Center

    Terre Haute, Indiana, United States

  • Tennessee Oncology

    Chattanooga, Tennessee, United States

  • Tennessee Oncology Pllc

    Nashville, Tennessee, United States

  • Center for Cancer and Blood Disorders

    Fort Worth, Texas, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
18 Dec 2014
Primary completion
31 Jan 2019
Completion
31 Jan 2019
Last update posted
17 Feb 2020
Registered enrollment
48
Registry id
NCT02291913

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.